Moderna, Inc.MRNANASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+273.2%
5Y CAGR+58.6%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+273.2%/yr
vs -9.9%/yr prior
5Y CAGR
+58.6%/yr
Recent acceleration
Acceleration
+283.1pp
Accelerating
Percentile
P97
Near historical high
vs 5Y Ago
10x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 2725.00% |
| Q3 2025 | -65.22% |
| Q2 2025 | 35.29% |
| Q1 2025 | -92.17% |
| Q4 2024 | -83.82% |
| Q3 2024 | 1165.09% |
| Q2 2024 | 49.30% |
| Q1 2024 | -96.23% |
| Q4 2023 | 559.51% |
| Q3 2023 | -5.94% |
| Q2 2023 | -137.00% |
| Q1 2023 | -67.63% |
| Q4 2022 | 52.41% |
| Q3 2022 | -33.44% |
| Q2 2022 | -35.30% |
| Q1 2022 | -17.91% |
| Q4 2021 | 46.02% |
| Q3 2021 | 18.53% |
| Q2 2021 | 123.55% |
| Q1 2021 | 179.23% |
| Q4 2020 | 271.53% |
| Q3 2020 | 154.31% |
| Q2 2020 | 6150.11% |
| Q1 2020 | -81.63% |
| Q4 2019 | -47.51% |
| Q3 2019 | 73.51% |
| Q2 2019 | -35.50% |
| Q1 2019 | -68.98% |
| Q4 2018 | -20.42% |
| Q3 2018 | 146.64% |
| Q2 2018 | -23.81% |
| Q1 2018 | -171.04% |
| Q4 2017 | 130.27% |
| Q3 2017 | 158.54% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |